GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hunan Jingfeng Pharmaceutical Co 000908.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

5.23

-2.61%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Hunan Jingfeng Pharmaceutical Co

Its shares trade on Shenzhen under the ticker 000908.SZ. It has been listed since 3 February 1999. In the fiscal year to 31 December 2025, it reported revenue of CN¥378.1m and a net loss of CN¥80.9m. At that date it held total assets of CN¥820.0m and shareholders' equity of CN¥23.1m.

Hunan Jingfeng Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of chemical and biological drugs. The company is headquartered in Shanghai, Shanghai. The firm's main products includes cardio and cerebrovascular drugs, antihypertensive and hypolipidemic drugs, orthopedic drugs, anti-tumor products, endocrine drugs, digestive system drugs, antiviral drugs and anti-infective drugs, among others. The firm is also involved in commodity import and export trading, business management and consulting, as well as medical technology consulting business. The firm distributes its products in the domestic market.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
3 Feb 1999
Employees
645
Website
jfyiyao.com ↗

Leadership

Pay as last reported

  • Ms. Li ZhangActing Chairman of the Board, Acting Secretary of the Board, since 2024
  • Mr. Dong YangPresident, Director, since 2024
  • Ms. Xuehong MaFinance Director, Director, since 2024
  • Ms. Gaojing YeDirector
  • Mr. Ting LiuIndependent Director
  • Mr. Yimin XuIndependent Director
  • Mr. Shaoxian ZhongIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Hunan Jingfeng Pharmaceutical Co Ltd focuses on cardio and cerebrovascular drugs in the Health Care sector.
  • The company employs 645 full-time employees specializing in pharmaceutical R&D and manufacturing.
  • Hunan Jingfeng distributes products domestically in China's pharmaceutical market.

Weaknesses

  • Hunan Jingfeng Pharmaceutical Co Ltd has no international market presence beyond China.
  • The company's product range lacks biotechnology-focused innovations in the Health Care industry.
  • Hunan Jingfeng's business model relies solely on domestic sales without export expansion.

Opportunities

  • Expanding into the Chinese domestic market for cardio and cerebrovascular drugs offers growth potential.
  • Increasing demand for antiviral and anti-infective drugs in China's Health Care sector.
  • Hunan Jingfeng can leverage its 645 employees for R&D in the pharmaceutical industry.

Threats

  • Competition from other Chinese pharmaceutical firms in the domestic market.
  • Regulatory changes in China's Health Care sector could impact product approvals.
  • Dependence on domestic market sales may limit growth opportunities.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.